Bli medlem
Bli medlem

Du är här

2020-03-19

BrainCool: BrainCool AB (publ) - order of BrainCool System in Germany

BrainCool has received an order from the University Hospital in
Erlangen, for the product BrainCool System. The order of one system
is from the department of neurology for the hypothermia treatment of
stroke patients. Delivery is scheduled for the end of March 2020.

CEO Martin Waleij comments

The order is important for two reasons, partly because Erlangen is one
of the leading clinics in Germany and partly that the product will be
used to treat stroke patients.

We also see the order as a confirmation that the market for intensive
care medical technology is prioritized even during the turbulence
with Covid 19. Although it is more difficult to book meetings with
hospitals in our direct sales markets USA and Germany, our
evaluations and processes are prioritized by the intensive care units
of hospitals.

For more information

Martin Waleij - CEO
+46 - 733 -93 70 76
E-mail: martin.waleij@braincool.se

About BrainCool AB (publ)

BrainCool AB (publ) is an innovative medical device company that
develops, markets, and sells leading medical cooling systems for
indications and areas with significant medical benefits within the
healthcare sector. The company focuses on two business segments,
Brain Cooling and Pain Management. BrainCool AB (publ) is based in
Lund, Sweden, and its share is listed on Spotlight Stock Market.

-----------------------------------------------------------
https://news.cision.com/se/braincool/r/braincool-ab--publ----order-of-br...
https://mb.cision.com/Main/11624/3064118/1214336.pdf

Författare AktieTorget News

Tala om vad ni tycker

Tala om vad ni tycker

Ni är just nu inne på en betaversion av nya aktiespararna. Lämna gärna feedback på vad ni tycker i formuläret nedan.